Notifications
Clear all
Topic starter
15/11/2022 10:59 pm
"Our study confirms that emodin is an effective primary therapy against the onset of genetic and chemically induced sporadic colorectal cancer. We established that emodin reduces the M2-like protumorigenic macrophages in the tumor microenvironment. Furthermore, we provide evidence that emodin may be acting to antagonize the P2X7 receptor within the bone tissue and consequently decrease the activation of proinflammatory cells, which may have implications for recruitment of cells to the tumor microenvironment."
https://journals.physiology.org/doi/abs/10.1152/ajpgi.00303.2021?journalCode=ajpgi